Logo image of BIO.DE

BIOTEST AG (BIO.DE) Stock Price, Quote, News and Overview

FRA:BIO - Deutsche Boerse Ag - DE0005227201 - Common Stock - Currency: EUR

42.2  0 (0%)

BIO.DE Quote, Performance and Key Statistics

BIOTEST AG

FRA:BIO (5/7/2025, 7:00:00 PM)

42.2

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High71.84
52 Week Low40.4
Market Cap1.67B
Shares39.57M
Float570.00K
Yearly Dividend0.04
Dividend YieldN/A
PE64.92
Fwd PE27.85
Earnings (Next)05-05 2025-05-05
IPO10-14 1987-10-14


BIO.DE short term performance overview.The bars show the price performance of BIO.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 1 2 3

BIO.DE long term performance overview.The bars show the price performance of BIO.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 0.5 -0.5

The current stock price of BIO.DE is 42.2 EUR. In the past month the price increased by 3.43%. In the past year, price decreased by -0.94%.

BIOTEST AG / BIO Daily stock chart

BIO.DE Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1ABBV.MI ABBVIE INC 18.38 294.00B
4AB.DE ABBVIE INC 18.08 289.05B
AMG.DE AMGEN INC 13.13 129.01B
1GILD.MI GILEAD SCIENCES INC 12.78 108.39B
GIS.DE GILEAD SCIENCES INC 12.63 107.06B
VX1.DE VERTEX PHARMACEUTICALS INC 1446.92 96.71B
ARGX.BR ARGENX SE 319.93 29.69B
22UA.DE BIONTECH SE-ADR N/A 20.18B
IDP.DE BIOGEN INC 7.43 15.17B
0QF.DE MODERNA INC N/A 8.36B
1MRNA.MI MODERNA INC N/A 8.14B
GLPG.AS GALAPAGOS NV N/A 1.49B

About BIO.DE

Company Profile

BIO logo image Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Company Info

BIOTEST AG

Landsteinerstr. 5

Dreieich HESSEN DE

Employees: 2495

BIO Company Website

Phone: 4961038010

BIOTEST AG / BIO.DE FAQ

What is the stock price of BIOTEST AG today?

The current stock price of BIO.DE is 42.2 EUR.


What is the ticker symbol for BIOTEST AG stock?

The exchange symbol of BIOTEST AG is BIO and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is BIO.DE stock listed?

BIO.DE stock is listed on the Deutsche Boerse Ag exchange.


What is BIOTEST AG worth?

BIOTEST AG (BIO.DE) has a market capitalization of 1.67B EUR. This makes BIO.DE a Small Cap stock.


How many employees does BIOTEST AG have?

BIOTEST AG (BIO.DE) currently has 2495 employees.


What are the support and resistance levels for BIOTEST AG (BIO.DE) stock?

BIOTEST AG (BIO.DE) has a support level at 42.12 and a resistance level at 42.4. Check the full technical report for a detailed analysis of BIO.DE support and resistance levels.


Is BIOTEST AG (BIO.DE) expected to grow?

The Revenue of BIOTEST AG (BIO.DE) is expected to grow by 11.95% in the next year. Check the estimates tab for more information on the BIO.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOTEST AG (BIO.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOTEST AG (BIO.DE) stock pay dividends?

BIO.DE does not pay a dividend.


When does BIOTEST AG (BIO.DE) report earnings?

BIOTEST AG (BIO.DE) will report earnings on 2025-05-05.


What is the Price/Earnings (PE) ratio of BIOTEST AG (BIO.DE)?

The PE ratio for BIOTEST AG (BIO.DE) is 64.92. This is based on the reported non-GAAP earnings per share of 0.65 and the current share price of 42.2 EUR. Check the full fundamental report for a full analysis of the valuation metrics for BIO.DE.


BIO.DE Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to BIO.DE. When comparing the yearly performance of all stocks, BIO.DE turns out to be only a medium performer in the overall market: it outperformed 58.11% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BIO.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to BIO.DE. BIO.DE has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BIO.DE Financial Highlights

Over the last trailing twelve months BIO.DE reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS decreased by -70.39% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.64%
ROA 1.84%
ROE 4.97%
Debt/Equity 1.2
Chartmill High Growth Momentum
EPS Q2Q%-109.28%
Sales Q2Q%10.42%
EPS 1Y (TTM)-70.39%
Revenue 1Y (TTM)-9.43%

BIO.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 46% to BIO.DE. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 1600% and a revenue growth 11.95% for BIO.DE


Ownership
Inst Owners0.21%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts45.71
Price TargetN/A
EPS Next Y1600%
Revenue Next Year11.95%